193 related articles for article (PubMed ID: 17875004)
1. The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies.
Fabrizi F; Takkouche B; Lunghi G; Dixit V; Messa P; Martin P
J Viral Hepat; 2007 Oct; 14(10):697-703. PubMed ID: 17875004
[TBL] [Abstract][Full Text] [Related]
2. Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?
Fabrizi F; Dixit V; Messa P
J Viral Hepat; 2012 Sep; 19(9):601-7. PubMed ID: 22863263
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis: Effect of hepatitis C virus infection on mortality in dialysis.
Fabrizi F; Martin P; Dixit V; Bunnapradist S; Dulai G
Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1271-7. PubMed ID: 15606388
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus and mortality among patients on dialysis: A systematic review and meta-analysis.
Fabrizi F; Dixit V; Messa P
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):244-254. PubMed ID: 30910601
[TBL] [Abstract][Full Text] [Related]
5. Risk of death among chronic dialysis patients infected with hepatitis C virus.
Stehman-Breen CO; Emerson S; Gretch D; Johnson RJ
Am J Kidney Dis; 1998 Oct; 32(4):629-34. PubMed ID: 9774125
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of observational studies: hepatitis C and survival after renal transplant.
Fabrizi F; Martin P; Dixit V; Messa P
J Viral Hepat; 2014 May; 21(5):314-24. PubMed ID: 24716634
[TBL] [Abstract][Full Text] [Related]
7. Health-related quality of life in dialysis patients with HCV infection.
Fabrizi F; Messa P; Martin P
Int J Artif Organs; 2009 Aug; 32(8):473-81. PubMed ID: 19844890
[TBL] [Abstract][Full Text] [Related]
8. Survival advantage of kidney transplantation over dialysis in patients with hepatitis C: a systematic review and meta-analysis.
Ingsathit A; Kamanamool N; Thakkinstian A; Sumethkul V
Transplantation; 2013 Apr; 95(7):943-8. PubMed ID: 23425817
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C-related liver disease in dialysis patients.
Fabrizi F; Dixit V; Messa P; Martin P
Contrib Nephrol; 2012; 176():42-53. PubMed ID: 22310780
[TBL] [Abstract][Full Text] [Related]
10. Differential Effect of Viral Hepatitis Infection on Mortality among Korean Maintenance Dialysis Patients: A Prospective Multicenter Cohort Study.
Kwon E; Cho JH; Jang HM; Kim YS; Kang SW; Yang CW; Kim NH; Kim HJ; Park JM; Lee JE; Jung HY; Choi JY; Park SH; Kim CD; Kim YL;
PLoS One; 2015; 10(8):e0135476. PubMed ID: 26263373
[TBL] [Abstract][Full Text] [Related]
11. Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease. The New England Organ Bank Hepatitis C Study Group.
Pereira BJ; Natov SN; Bouthot BA; Murthy BV; Ruthazer R; Schmid CH; Levey AS
Kidney Int; 1998 May; 53(5):1374-81. PubMed ID: 9573555
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C treatment in patients with kidney disease.
Fabrizi F; Aghemo A; Messa P
Kidney Int; 2013 Nov; 84(5):874-9. PubMed ID: 23823603
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C and Its Metabolic Complications in Kidney Disease.
Fabrizi F; Donato FM; Messa P
Ann Hepatol; 2017 November-December,; 16(6):851-861. PubMed ID: 29055921
[TBL] [Abstract][Full Text] [Related]
14. Effect of dialysis modality on survival of hepatitis C-infected ESRF patients.
Bose B; McDonald SP; Hawley CM; Brown FG; Badve SV; Wiggins KJ; Bannister KM; Boudville N; Clayton P; Johnson DW
Clin J Am Soc Nephrol; 2011 Nov; 6(11):2657-61. PubMed ID: 21903989
[TBL] [Abstract][Full Text] [Related]
15. Risk of death and liver cirrhosis in anti-HCV-positive long-term haemodialysis patients.
Espinosa M; Martin-Malo A; Alvarez de Lara MA; Aljama P
Nephrol Dial Transplant; 2001 Aug; 16(8):1669-74. PubMed ID: 11477172
[TBL] [Abstract][Full Text] [Related]
16. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
Fabrizi F; Donato FM; Messa P
Ann Hepatol; 2018; 17(3):364-391. PubMed ID: 29735788
[TBL] [Abstract][Full Text] [Related]
17. [The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies].
Fabrizi F; Messa P
G Ital Nefrol; 2012; 29 Suppl 56():S78-84. PubMed ID: 23059944
[TBL] [Abstract][Full Text] [Related]
18. Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand.
Scott DR; Wong JK; Spicer TS; Dent H; Mensah FK; McDonald S; Levy MT
Transplantation; 2010 Dec; 90(11):1165-71. PubMed ID: 20861806
[TBL] [Abstract][Full Text] [Related]
19. Recent advances on hepatitis C virus in dialysis population.
Fabrizi F; Messa P; Martin P
Kidney Blood Press Res; 2014; 39(4):260-71. PubMed ID: 25171295
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
Fabrizi F; Dixit V; Martin P; Messa P
J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
